LP Portal

Secure access for limited partners.

Having trouble? Contact us

Internal AI Platform

Secure access for authorized users.

Having trouble? Contact us
Founded by Operators. Anchored by strategics.

Advancing Medtech Innovation

Star51 Capital is a venture investment platform bridging the gap between innovation and acquisition. Anchored by a leading healthcare system and a global Medtech strategic, we invest at the convergence of Medtech and AI.

About Star51
An Ecosystem Fund Designed for the Medtech-AI Era

Star51 Capital is a venture investment vehicle designed to bridge the gap between innovation and acquisition. Anchored by a leading healthcare system and a top-tier global Medtech strategic, the fund focuses specifically on the convergence of Medtech and AI, leveraging deep industry ties to accelerate market entry and liquidity.

⚖

Strategic Anchors

Leading healthcare system and a top-5 global Medtech strategic providing clinical validation, commercialization pathways, and domain expertise beyond capital.

★

Operator-Led

Managed by founders turned investors who have built, scaled, and exited Medtech companies. We understand the acquirer's mind.

✈

Global Deal Flow

High-conviction opportunities sourced from the US, Europe, and Israel at the intersection of Medtech and AI.

⇄

Innovation to Acquisition

An integrated ecosystem that bridges the gap between innovation and acquisition, building companies that are both acquirable and in high demand by strategics.

Investment Focus
The Intersection of Medtech & AI

Therapies, Diagnostics & Monitoring

Personalization of Healthcare Delivery

Digitalization of Healthcare

Our Team
Leadership
Adam Rosenwach

Adam Rosenwach

Founding Managing Partner

CFO for high-growth Medtech startups including Axon, Coridea, and Deerfield Catalyst. Expert in navigating complex financial structures and venture scaling. Berklee College of Music, Wharton MBA.

Tal Wenderow

Tal Wenderow

Founding Managing Partner

Founder of Corindus Vascular Robotics. Led the company through its full lifecycle to a $1.1B acquisition by Siemens Healthineers. Former Venture Partner for a global Medtech strategic.

Anna Hildebrand

Anna Hildebrand

Inaugural Principal

Medtech investor at IAG Capital Partners. Bioengineering MRes, Imperial College London. B.E., Vanderbilt University.

Operating Partners
Raymond Cohen

Raymond Cohen

Multi-exit CEO/Chairman
Scott Pantel

Scott Pantel

Founder & CEO, LSI
Joe Mullings

Joe Mullings

Chairman & CEO, The Mullings Group
Domain Experts & Venture Partners
Nir Goldenberg

Nir Goldenberg

Senior Dir Business Development, Mayo Clinic BD
Howard Levin

Howard Levin, MD

Cardiovascular Expert
Patrick Mitchell

Patrick Mitchell

Finance Expert
Anjan Chatterji

Anjan Chatterji

Serial Investor/Founder
Jessica Richter

Jessica Richter

Founder & CEO, RAC
Mark Gelfand

Mark Gelfand

IP / Serial Founder
Ken Nelson

Ken Nelson

Commercial Leader
Henry Peck

Henry Peck

CBO, LSI
Josh Defonzo

Josh Defonzo

CEO, Mendaera
Michael Tutera

Michael Tutera

Market Access & Reimbursement
News
Press Release
June 11, 2026

Star51 Capital Announces First Close of Medtech Venture Fund

Star51 Capital announced the first close of its inaugural fund, led by Abbott and Mayo Clinic, with participation from senior Medtech executives, physicians, and life science professionals. The operator-led ecosystem fund invests at the convergence of Medtech and AI.

Read Full Release

We invest in companies at the intersection of Medtech and AI, building stronger pathways to success and cultivating a collaborative ecosystem designed to generate competitive returns and lasting patient impact.

Get in Touch

We'd love to hear from you. Fill out the form below and we'll be in touch shortly.

Or email us directly at info@star51capital.com